ERBB2 and breast carcinoma: Recently, a study done on non-luminal breast cancers (Her2+ and TNBC), published in EBioMedicine, identified soluble APPα that is generated by ADAM10 cleavage of APP, as important in breast cancer tumor migration and proliferation (81).